Long‐term outcomes of anti‐thyroid drug treatment in childhood‐onset Graves' disease

In simple terms

This study watched a group of kids with an overactive thyroid over many years and noticed that those who took medicine longer were more likely to get better. But it didn’t make anyone take the medicine longer — it just looked at what already happened, so we can’t say the medicine itself caused the improvement.

50%

Analysis score

50/ 72

Maximum 72 for a cohort study.

Where the score came from

Reporting0

Methodology31

Publication100

Statistical77

Study type (basis of the score)

Cohort Study

Level 2b - Individual cohort study

What’s the bottom line?

Some kids get an overactive thyroid called Graves' disease and take pills to calm it down. This study looked at what happened to them years later.

Where does this study sit?

Reviews of RCTs (Meta-analyses)

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5

StrongerWeaker

Cohort Studies

Level 2b

50 / 100

Quality score

Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.

Cannot establish causation

Save studies & get personalized insights

Create a free account to save this study, track new evidence as it comes in, and get breakdowns of studies in the topics you care about.

Key takeaways

Summary

Based on the study abstract and findings.

1Most kids didn't stay in remission after stopping pills, and many got sick again quickly — suggesting longer treatment might help, but it's not a cure for most.
221% of kids got better and stayed better after stopping pills; 40% of those who stopped got sick again, and half of those came back within one year.

Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data